Clinical trial
Vector Delivery of the IL-12 Gene in Men With Prostate Cancer
NCT00406939 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00406939 |
|---|---|
| Title | Vector Delivery of the IL-12 Gene in Men With Prostate Cancer |
| Official title | Phase I Study of Adenoviral Vector Delivery of The IL-12 Gene in Men With Recurrence or Persistent Cancer of the Prostate After Primary Therapy With or Without Metastatic Disease (SPORE) |
| Lead sponsor | Baylor College of Medicine, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostatic Neoplasms, Prostate Cancer |
| Intervention type | Genetic |
| Interventions | IL-12 gene |
| Enrollment | 4 |
| Start date | Jun 1, 1998 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Dec 4, 2006 |
| Last update posted | Jul 10, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: